Clinical Trials Browser

Phase 2 × Waldenstrom Macroglobulinemia × loncastuximab tesirine × Clear all

NCT05190705 2026-05-20

Loncastuximab Tesirine in WM

Phase 2 Active not recruiting

Waldenstrom Macroglobulinemia